Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Cancer|September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancerM Gutman, S Abu-Abid, P Sorkine, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II studyO Merimsky, I Meller, G Flusser, et al.
Annals of Surgical Oncology|April 13, 2000
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerationsJ Issakov, O Merimsky, M Gutman, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifenJ Atzpodien, E Lopez Hänninen, H Kirchner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1987
Prognostic factors in breast cancer--a pathological and immunological study of patients with stage 1 breast cancerS Chaitchik, B Kabakow, A De Chabon, et al.
American Journal of Clinical Oncology|July 28, 2001
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter studyI G Ron, N Wigler, R Borovik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2O Merimsky, E Gez, R Weitzen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS)A Zer, O Icht, L Yosef, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 17